Court Opinion

ID: 6800887
Source: CourtListenerOpinion
Date Created: 2022-07-22 20:01:16.155082+00
Date Added: 2024-06-11T16:03:14.736125
License: Public Domain

UNITED STATES DISTRICT COURT
                           FOR THE DISTRICT OF COLUMBIA

PHILIP HANSTEN,                                 :
                                                :
       Plaintiff,                               :      Civil Action No.:      21-2043 (RC)
                                                :
       v.                                       :      Re Document Nos.:      11, 12
                                                :
DRUG ENFORCEMENT                                :
ADMINISTRATION,                                 :
                                                :
       Defendant.                               :

                                MEMORANDUM OPINION

    GRANTING PLAINTIFF’S MOTION FOR SUMMARY JUDGMENT; DENYING DEFENDANT’S
               MOTION FOR SUMMARY JUDGMENT WITHOUT PREJUDICE

                                     I. INTRODUCTION

       This case arises out of a Freedom of Information Act (“FOIA”) dispute between Plaintiff

Philip Hansten and Defendant Drug Enforcement Administration (“DEA”). Mr. Hansten asked

the DEA to produce certain information concerning drug purchase order forms (“Form 222s”)

that it issued on a single day in 2011. The DEA refused, claiming that any responsive records

would be categorically exempt under FOIA Exemption 7(E). But the DEA’s position lacks

merit. For the reasons described below, the Court finds that release of the requested Form 222

information would not reveal any law enforcement technique or procedure. The Court will

therefore order the DEA to conduct a search and produce all responsive non-exempt information,

and, to the extent that the DEA withholds any responsive information pursuant to FOIA, renew

its motion for summary judgment thereafter.
                   II. FACTUAL AND PROCEDURAL BACKGROUND

       The DEA is a federal agency whose mission is to enforce the controlled substance laws

and regulations of the United States. Hertel Decl. ¶ 5, ECF No. 12-5. The DEA administers the

Controlled Substances Act, which established a closed system of distribution that allows the

DEA to trace drugs from initial manufacture to final dispensing. Id. ¶ 10; 21 U.S.C. § 828.

These drugs are classified into five schedules, which are published annually. Hertel Decl. ¶ 10.

The closed system of distribution allows the DEA to prevent, investigate, and prosecute

“diversion,” or drug transactions that occur outside the system. Def. Mot. Summ. J. (“Def.

MSJ”) at 3, ECF No. 12-1. Under the system, anyone who handles Schedule I or II drugs must

register with the DEA. See 28 U.S.C. § 823 (registration requirements). In addition, to order

and transfer such drugs, a registrant must complete a standard purchase order form called Form

222. Hertel Decl. ¶ 10. This process begins when a registrant requests a Form 222 from the

DEA. Def.’s Opp’n Pl.’s Mot. Summ. J. (“Def. Opp’n”) at 3, ECF No. 14 (citing 21 C.F.R.

§ 1305.11(b) (2019)). The DEA then sends a Form 222 to the registrant that contains pre-printed

information, as required by regulation, including [1] an order form number bearing the [2] name,

[3] address, and [4] registration number of the registrant, [5] the authorized activity, and [6] drug

schedules of the registrant. 21 C.F.R. § 1305.11(d) (2019); Hertel Decl. ¶ 10; see Ex. 5 to Def.

MSJ (“Sample Form 222”), ECF No. 12-8 (entries for “No. of this Order Form”; “Name and

Address of Registrant”; “DEA Registration No.”; “Registered as a”; and “Schedules”). Once the

parties involved in a drug transaction fill out the remaining entries in the Form 222 (such as drug

name, code, and package number/size), the DEA stores the completed form in a non-public

database for regulatory and investigative use. Def. MSJ at 4; Hertel Decl. ¶ 16; Sample Form

222 (green copy denoting “DEA Copy 2”).

                                                  2
       Mr. Hansten is a professor with an academic and professional interest in drug

interactions. Hansten Decl. ¶¶ 1–2, ECF No. 11-3. On March 10, 2021, he submitted a FOIA

request to the DEA seeking “[r]ecords sufficient to show the names, addresses, and business

activities of all parties that were issued DEA Form 222s in which the ‘Date Issued’ on the form

is 05/11/2011 (May 11, 2011).” Ex. A to Hansten Decl. (“Request Letter”). Mr. Hansten

received an automatic courtesy reply from the DEA on the same day. Ex. B to Hansten Decl. A

few weeks later, he contacted the DEA to request a FOIA number and an acknowledgement

letter. Ex. C to Hansten Decl. The DEA responded with another courtesy reply on April 7,

2021, which provided him a FOIA number but did not provide an estimated timeline for an

acknowledgement letter. Ex. D to Hansten Decl. Having received no further communication

from the DEA, Mr. Hansten filed suit on July 28, 2021. Compl., ECF No. 1.

       A month into this lawsuit, the DEA responded to Mr. Hansten’s request, claiming that

any responsive records were “categorically exempt from disclosure pursuant to 5 U.S.C.

§ 552(b)(7)(E)” and therefore it was “not required to conduct a search for the requested records.”

Ex. E to Hansten Decl. (“Response Letter”). The DEA then filed its answer, and subsequently

the parties both moved for summary judgment. Pl.’s Mot. Summ. J. (“Pl. MSJ”), ECF No. 11;

Def. MSJ. In support of its motion, the DEA submits the declaration of Angela D. Hertel, Unit

Chief of the Legal and External Affairs Unit of the DEA. Hertel Decl. ¶ 1. The DEA did not

submit a Vaughn index.

                                   III. LEGAL STANDARD

       The Freedom of Information Act is meant “to pierce the veil of administrative secrecy

and to open agency action to the light of public scrutiny.” U.S. Dep’t of State v. Ray, 502 U.S.

164, 173 (1991) (quoting Dep’t of Air Force v. Rose, 425 U.S. 352, 361 (1976)). It “directs that

                                                3
‘each agency, upon any request for records . . . shall make the records promptly available to any

person’ unless the requested records fall within one of the statute’s nine exemptions.” Loving v.

Dep’t of Def., 550 F.3d 32, 37 (D.C. Cir. 2008) (quoting 5 U.S.C. § 552(a)(3)(a)). “Consistent

with the Act’s goal of broad disclosure,” those exemptions should be “given a narrow compass.”

U.S. Dep’t of Just. v. Tax Analysts, 492 U.S. 136, 151 (1989). “The agency bears the burden of

establishing that a claimed exemption applies.” Citizens for Resp. & Ethics in Wash. v. U.S.

Dep’t of Just. (“CREW”), 746 F.3d 1082, 1088 (D.C. Cir. 2014).

       Summary judgment is warranted “if the movant shows that there is no genuine dispute as

to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P.

56(a). In assessing whether the movant has met that burden, a court “must view the evidence in

the light most favorable to the nonmoving party, draw all reasonable inferences in his favor, and

eschew making credibility determinations or weighing the evidence.” Montgomery v. Chao, 546

F.3d 703, 706 (D.C. Cir. 2008). Because FOIA cases do not ordinarily involve disputed facts,

they “are typically and appropriately decided on motions for summary judgment.” Moore v.

Bush, 601 F. Supp. 2d 6, 12 (D.D.C. 2009) (citations omitted). An agency may show that it is

entitled to summary judgment by submitting affidavits that, in “reasonably specific detail,

demonstrate that the information withheld logically falls within the claimed exemption, and are

not controverted by either contrary evidence in the record nor by evidence of agency bad

faith.” Id. (quoting Mil. Audit Project v. Casey, 656 F.2d 724, 738 (D.C. Cir. 1981)). An

agency’s justification for withholding records “is sufficient if it appears ‘logical’ or

‘plausible.’” Larson v. Dep’t of State, 565 F.3d 857, 862 (D.C. Cir. 2009) (quoting Wolf v. CIA,

473 F.3d 370, 375 (D.C. Cir. 2007)).

                                                  4
                                         IV. ANALYSIS

       The DEA’s sole basis for claiming a categorical exemption and refusing to search for

responsive documents is Exemption 7(E). This exemption protects from disclosure “records or

information compiled for law enforcement purposes, but only to the extent that the production of

such law enforcement records or information . . . would disclose techniques and procedures for

law enforcement investigations or prosecutions, or would disclose guidelines for law

enforcement investigations or prosecutions if such disclosure could reasonably be expected to

risk circumvention of the law.” 5 U.S.C. § 552(b)(7)(E). A record must therefore meet three

requirements to qualify for withholding pursuant to Exemption 7(E). See Advancement Project

v. U.S. Dep’t of Homeland Sec., 549 F. Supp. 3d 128, 142 (D.D.C. 2021). First, it must have

been “compiled for law enforcement purposes.” Id. That means that the record was “created,

gathered, or used by an agency for law enforcement purposes at some time before the agency

invokes the exemption.” Pub. Emps. for Env’t Resp. v. U.S. Section, Int’l Boundary & Water

Comm’n, U.S.-Mex. (“PEER”), 740 F.3d 195, 203 (D.C. Cir. 2014). Second, the release of the

record must disclose techniques, procedures, or guidelines used for law enforcement

investigations or prosecutions. 5 U.S.C. § 552(b)(7)(E). Third, the disclosure of those

techniques, procedures, or guidelines “could reasonably be expected to risk circumvention of the

law.” Id.1 In other words, disclosure “might increase the risk ‘that a law will be violated or that

       1
         According to D.C. Circuit caselaw, an Exemption 7(E) claimant must show a risk of
circumvention of the law regardless of whether a law enforcement technique, procedure, or
guideline is at stake. See PEER, 740 F.3d at 204 n.4 (remarking that, unlike the Second Circuit,
the D.C. Circuit has applied the “risk of circumvention” requirement to techniques and
procedures in addition to guidelines). In this case, the DEA contends that release of the Form
222 information would disclose “techniques and procedures.” Response Letter at 1; Pl.’s Opp’n
Def.’s Mot. Summ. J. (“Pl. Opp’n”) at 7 n.2, ECF No. 15.
      In addition, the “could reasonably be expected to risk” language supplants the FOIA
Improvement Act’s general requirement that an agency must disclose records unless it is

                                                 5
past violators will escape legal consequences.’” PEER, 740 F.3d at 205 (quoting Mayer Brown

LLP v. IRS, 562 F.3d 1190, 1193 (D.C. Cir. 2009)).

                         A. Compiled for Law Enforcement Purposes

       Exemption 7(E) first requires that the record was “compiled for law enforcement

purposes.” 5 U.S.C. § 552(b)(7). An agency whose “principal function is law enforcement” is

entitled to deference when it claims that records were compiled for law enforcement purposes.

PEER, 740 F.3d at 203. Yet this deferential standard of review is not “vacuous.” Campbell v.

U.S. Dep’t of Just., 164 F.3d 20, 32 (D.C. Cir. 1998) (quoting Pratt v. Webster, 673 F.2d 408,

421 (D.C. Cir. 1982)). Even a law enforcement agency must establish: (1) “a rational nexus

between the investigation and one of the agency’s law enforcement duties,” and (2) “a

connection between an individual or incident and a possible security risk or violation of federal

law.” Blackwell v. F.B.I., 646 F.3d 37, 40 (D.C. Cir. 2011). A law enforcement purpose can

exist “outside the context of a specific investigation.” Tax Analysts v. I.R.S., 294 F.3d 71, 78

(D.C. Cir. 2002).

       Here, the DEA’s principal function is law enforcement. See Cooper v. U.S. Dep’t of

Just., No. 99-cv-2513, 2022 WL 602532, at *28 (D.D.C. Mar. 1, 2022); Deglace v. D.E.A., No.

05-cv-2276, 2007 WL 521896, at *2 (D.D.C. Feb. 15, 2007). Thus, the Court views the DEA’s

representation that Form 222s are compiled for law enforcement purposes in a deferential light.

The DEA’s mission is “to regulate the distribution of controlled substances for lawful uses.”

Def. MSJ at 4–5. According to the DEA, Form 222s serve this mission because it is “collected

reasonably foreseeable that disclosure would harm the interest the claimed exemption protects.
See Reps. Comm. for Freedom of the Press v. FBI, 548 F. Supp. 3d 185, 197 & n.2 (D.D.C.
2021); Citizens for Resp. & Ethics in Wash. v. U.S. Dep’t of Homeland Sec., 525 F. Supp. 3d
181, 192 & n.4 (D.D.C. 2021).

                                                 6
in furtherance of DEA’s diversion control enforcement.” Id. Mr. Hansten, however, points out

that the pre-printed information on Form 222s is supplied by the registrants themselves and

contends that the DEA merely “compiles this information as part of a routine recordkeeping

process.” Pl. MSJ at 13 (citing 21 C.F.R. § 1305.11 (2019)). But the DEA has explained that

Form 222 is a “critical tool[]” that allows it “to regulate the distribution of controlled substances

for lawful uses,” Def. MSJ at 4–5, and that “information collected from registrants” assists the

“DEA’s efforts to track the distribution of controlled substances for particular transactions,”

Hertel Decl. ¶ 16. So, Form 222 enables the DEA to uncover and investigate diversion

“incident[s]” in “violation of federal law.” Blackwell, 646 F.3d at 40. Given Form 222’s

function, the “nexus” between it and the DEA’s mission is plainly “rational.” Id.; cf.

Greenpeace, Inc. v. Dep’t of Homeland Sec., 311 F. Supp. 3d 110, 128 (D.D.C. 2018) (finding

DHS’s records collection of chemical facilities regulated by law served law enforcement purpose

under Exemption 7 because “[s]teps by law enforcement officers to prevent terrorism surely

fulfill ‘law enforcement purposes’” (quotation marks and citation omitted)). Still, Mr. Hansten

argues, if this form of recordkeeping serves a law enforcement purpose, virtually all records of a

law enforcement agency would qualify as serving some law enforcement purpose. Pl. Opp’n at

15. But Mr. Hansten’s argument sweeps too broadly, as there is a rational nexus here between

the Form 222s and the DEA’s law enforcement function of controlling drug diversion where

there would likely not be with records concerning the procurement of office supplies or

maintenance of fleet vehicles. Accordingly, the DEA has cleared the preliminary hurdle

imposed by Exemption 7(E) by establishing that the requested Form 222 information was

compiled for law enforcement purposes.

                                                  7
    B. Techniques and Procedures for Law Enforcement Investigations or Prosecutions

       In order to meet Exemption 7(E)’s second requirement, the DEA must show that release

would “disclose techniques and procedures for law enforcement investigations or prosecutions.”

5 U.S.C. § 552(b)(7)(E). “The phrase ‘techniques and procedures’ . . . refers to how law

enforcement officials go about investigating a crime.” Whittaker v. United States Dep’t of Just.,

No. 18-cv-01434, 2019 WL 2569915, at *2 (D.D.C. June 21, 2019) (emphasis in original)

(quoting Allard K. Lowenstein Int’l Human Rights Project v. Dep’t of Homeland Sec., 626 F.3d

678, 682 (2d Cir. 2010)). An agency cannot justify an Exemption 7(E) withholding by offering a

“near-verbatim recitation of the statutory standard” that does nothing to explain “what

procedures are at stake” or “how disclosure [of the withheld records] could reveal such

procedures.” CREW, 746 F.3d at 1102. The agency “must at least provide some explanation of

what procedures are involved and how they would be disclosed.” Id. (emphasis in original).

Furthermore, “[t]he government ‘must show that the records contain law-enforcement techniques

and procedures that are generally unknown to the public.” Elkins v. Fed. Aviation Admin., 134 F.

Supp. 3d 1, 4 (D.D.C. 2015) (quoting Am. Immigr. Council v. U.S. Dep’t of Homeland Sec., 950

F. Supp. 2d 221, 245 (D.D.C. 2013)). The exemption “does not ordinarily protect ‘routine

techniques and procedures already well known to the public,’” but it does “protect ‘confidential

details . . . of program[s]’ if only their ‘general contours [are] publicly known.’” Elec. Frontier

Found. v. Dep’t of Just., 384 F. Supp. 3d 1, 9–10 (D.D.C. 2019) (omission and alterations in

original) (first quoting Founding Church of Scientology of Wash., D.C. v. NSA, 610 F.2d 824,

832 n.67 (D.C. Cir. 1979); and then quoting Sussman, 494 F.3d at 1112).

       Here, the DEA cannot meet Exemption 7(E)’s second requirement. While the DEA

could use Form 222 in a diversion investigation, the entries on this form say nothing about how

the DEA would “go about investigating” a diversion case. Whittaker, 2019 WL 2569915, at *2

                                                 8
(emphasis in original); see also Transgender L. Ctr. v. ICE, 33 F.4th 1186, 1199 (9th Cir. 2022)

(“‘[T]echniques and procedures’ cover ‘how law enforcement officials go about investigating a

crime.’” (citation omitted)); Broward Bulldog, Inc. v. U.S. Dep’t of Just., 939 F.3d 1164, 1191

(11th Cir. 2019) (same). The DEA does not dispute that Form 222s are required for every entity

seeking to purchase and transfer Schedule I or II drugs. Pl. MSJ at 2. Nor does it contest Mr.

Hansten’s claim that “[t]he majority, if not all of the DEA registrants issued DEA Forms 222 on

a specific date are legitimate pharmacies, doctors, and state functions.” Id. at 14. Given this

context, the DEA has not explained how anything in these standard purchase forms would reveal

any “technique” or “procedure” regarding the DEA’s diversion enforcement. See Webster’s

Third New International Dictionary (1986) (defining “technique” as “a technical method of

accomplishing a desired aim”; and “procedure” as “a particular way of doing or of going about

the accomplishment of something”). Furthermore, Form 222 is not “generally unknown to the

public,” Elkins, 134 F. Supp. 3d at 4, given the fact that Congress mandates its use, 21 U.S.C.

§ 828(d)(1), and federal regulation specifies the pre-printed information on it. See 21 C.F.R.

§ 1305.11(d) (2019) (“DEA Forms 222 will have an order form number and be issued with the

name, address and registration number of the registrant, the authorized activity, and schedules of

the registrant.”). Perhaps the DEA applies specific law enforcement techniques to the

information contained in the Form 222s to investigate drug diversion. But the DEA entirely fails

to disclose how the information contained in the form reveals the law enforcement technique

itself. In short, Form 222 reveals nothing about the agency’s law enforcement techniques and

procedures, and the type of information collected, as well as the fact that it is collected, is already

generally known.

                                                  9
       Two recent cases in this District help drive this point home. In Whittaker v. United States

Department of Justice, the plaintiff sought records of the FBI’s background check on him. No.

18-cv-01434, 2020 WL 6075681, at *1 (D.D.C. Oct. 15, 2020). The FBI claimed Exemption

7(E) on the basis that the background check would reveal the agency’s techniques and

procedures. Id. at *2. It explained in detail that disclosure of the background check would

reveal FBI techniques and procedures because based on what information, if any, appeared, a

criminal could determine whether the FBI had detected her criminal activity and draw inferences

about the FBI’s capabilities to detect and deter her crime. Id. at *3. In ruling for the FBI, the

court found that the FBI adequately showed that “disclosing information risks revealing the

underlying techniques and procedures used to gather information about a person.” Id. at *4.

       In Woodward v. U.S. Marshals Service, plaintiff sought records pertaining to cell phone

tracking technology used by the agency that led to his criminal conviction. No. 18-cv-1249,

2022 WL 296171, at *1 (D.D.C. Feb. 1, 2022). The court ruled that because the public was

aware of the “general contours” of cell data tracking, the agency could not redact the section of

the document merely “indicating its existence.” Id. at *6. The agency was entitled, however, to

redact the list of phone numbers it compiled that were associated with the fugitive. Id. The court

reasoned that “[t]he list of specific phone numbers could provide insight on law enforcement

investigation techniques,” such as “who law enforcement investigated in connection to the

Plaintiff for apprehension purposes” and “the numbers that were investigated.” Id. (citation

omitted).

       Unlike the protected information in Whittaker and Woodward, the requested Form 222

information does not reveal any DEA techniques or procedures. These Form 222 entries say

nothing about how the DEA would “go about” a diversion investigation. Whittaker, 2019 WL

                                                 10
2569915, at *2. Because every registrant seeking to buy and transfer Schedule I and II drugs

must complete a Form 222, the data on the form would not reveal the DEA’s investigative

capabilities (as was the case in Whittaker) or who it was investigating (as was the case in

Woodward). In short, the DEA has failed to explain how any technique or procedure can be

divined from a Form 222.

       The DEA, for its part, shifts the Court’s attention to the procurement of lethal injection

drugs, claiming that disclosure of Form 222s would jeopardize this system.2 According to the

DEA, “any responsive records may reveal the identity of a provider of controlled substances

used in lethal injections” and therefore “impair the government’s ability to obtain lethal injection

substances in the future.” Hertel Decl. ¶ 17; Def. MSJ at 10–11. The Court, however, agrees

with Mr. Hansten that these arguments “have no bearing on the applicability of Exemption 7(E),”

Pl. Opp’n at 14, because Exemption 7(E) only protects disclosures that would reveal “techniques

and procedures for law enforcement investigations or prosecutions.” 5 U.S.C. § 552(b)(7)(E)

(emphasis added). As a court in this District explained, records concerning lethal injection are

part of the “punishment phase” of the criminal process, which is distinct from the “investigation

and prosecution phases of the criminal process” under the “plain meaning” of Exemption 7(E).

Citizens for Resp. & Ethics in Wash. v. U.S. Dep’t of Just., 567 F. Supp. 3d 204, 217 (D.D.C.

2021) (rejecting Federal Bureau of Prisons’s withholding under Exemption 7(E) of records

       2
          The DEA initially appeared to justify its withholding based on “Plaintiff’s identity” as a
death penalty abolitionist and his “purported purpose behind the request,” but the agency
subsequently clarified that it concurred with Mr. Hansten that these considerations are irrelevant
to its withholding. See Def. MSJ at 4–6, 10, 11; Def.’s Reply Support Mot. Summ. J. (“Def.
Reply”) at 2 n.1, ECF No. 16. The Court agrees. See U.S. Dep’t of Just. v. Reps. Comm. for
Freedom of Press, 489 U.S. 749, 771 (1989) (“[T]he identity of the requesting party has no
bearing on the merits of his or her FOIA request.”); North v. Walsh, 881 F.2d 1088, 1096 (D.C.
Cir. 1989) (“[A party’s] need or intended use for the documents is irrelevant to his FOIA
action”).

                                                 11
concerning procurement of lethal injection drugs). Citizens, however, acknowledged that

information concerning lethal injection may satisfy Exemption 7’s “law enforcement purpose”

requirement because “enforcement of the law fairly includes . . . the detection and punishment of

violations of law.” Id. at 215 (emphasis in original) (quoting Mittleman v. Office of Personnel

Mgmt., 76 F.3d 1240, 1243 (D.C. Cir. 1996)); see 5 U.S.C. § 552(b)(7) (Exemptions 7(A)–(F)

each requires showing law enforcement purpose). Thus, once the DEA has searched for and

processed the responsive records, perhaps there will be a basis to withhold any lethal injection-

related information under another subsection of Exemption 7, but the DEA has failed to establish

a basis under Exemption 7(E) on the current record. In conclusion, the DEA has failed to show

that disclosure of Form 222 information reveals any law enforcement technique or procedure.

Accordingly, it is unnecessary for the Court to examine Exemption 7(E)’s last requirement

regarding risk of circumvention.

                                   *             *               *

       Within 60 days, the DEA must conduct a search for responsive records and produce to

Mr. Hansten any non-exempt portions of such records. To the extent that the DEA withholds

any responsive information pursuant to FOIA, it shall renew its motion for summary judgment

30 days thereafter. To move the remaining issues forward in this case, the DEA must clarify a

few points.

       First, the DEA has not explained precisely what records it claims are exempt from

disclosure. The DEA has treated Mr. Hansten’s request as a “request for DEA Form 222s.” Def.

Opp’n at 2. But Mr. Hansten’s request is broader: he seeks “[r]ecords sufficient to show the

names, addresses, and business activities of all parties that were issued DEA Form 222s.”

Request Letter at 1 (emphasis added). It is true that Form 222 is itself a record bearing this

                                                 12
information. See Hertel Decl. ¶ 10; 21 C.F.R. § 1305.11(d) (2019) (requiring “name,

address . . . of the registrant, the authorized activity”); Sample Form 222 (entries for “Name and

Address of Registrant” and “Registered as a”). But it remains unclear whether any other records

may also supply the requested information. See, e.g., Hertel Decl. ¶ 10 (mentioning “electronic

equivalent” to DEA Form 222). Accordingly, the DEA must conduct a search for all responsive

records. See Oglesby v. U.S. Dep’t of Army, 920 F.2d 57, 68 (D.C. Cir. 1990) (agency has duty

to verify that “all files likely to contain responsive materials (if such records exist) were

searched”).

       Second, in the event the DEA renews its motion for summary judgment, it must clarify

which Form 222 it possesses. When the DEA refers to Form 222 in its briefing, is it referring to

the pre-printed form that the DEA sends to registrants? See Hertel Decl. ¶ 14; Sample Form

222. Or is it referring to the completed form that bears the pre-printed entries in addition to the

entries that the parties fill out after a drug transaction? See Def. Reply at 5. Or does the DEA

possess both kinds of Form 222s? Moreover, does the DEA possess an electronic database of

Form 222 information submitted electronically that can be searched and from which selective

information can be extracted? All of these distinctions are important because the type of content

on a Form 222 will inform the Court’s analysis of what, if any, exemptions apply and to which

portions they might apply.

                                        V. CONCLUSION

       For the foregoing reasons, Plaintiff’s Motion for Summary Judgment (ECF No. 11) is

GRANTED and Defendant’s Motion for Summary Judgment (ECF No. 12) is DENIED

WITHOUT PREJUDICE. Within 60 days of this Opinion, the DEA shall: (1) conduct a search

for responsive records; and (2) produce to Mr. Hansten any non-exempt portions of such records.

                                                  13
To the extent that the DEA withholds any responsive information pursuant to FOIA, it shall

renew its motion for summary judgment 30 days thereafter. An order consistent with this

Memorandum Opinion is separately and contemporaneously issued.

Dated: July 22, 2022                                            RUDOLPH CONTRERAS
                                                                United States District Judge

                                              14